Profits Pending

For some, biotech will be a life-saver. But Albright deftly demonstrates how the industry actually stifles innovation. Patent holders stop development of promising drugs—because the companies won’t get a large enough financial reward. And the threat of costly patent infringement suits shuts down critical research. Put baldly, patents are killing people. Albright aims to set it right.